Atul Analyst Meet 2026: Improving performance, disciplined capital, and a long runway
Ask Iris
/n
Frequently Asked Questions
Revenue from operations was 6,274 crore, EBITDA was 1,234 crore (20% margin), and PAT was 689 crore.
Life Science Chemicals reported net revenue 1,805 crore with EBIT 417 crore (23% margin). Performance and Other Chemicals reported net revenue 4,609 crore with EBIT 417 crore (9% margin).
Net cash inflow from operating activities was 1,023 crore. Treasury funds (net of borrowings) increased to 1,578 crore.
It stated sales yet to realise of 600 crore from new projects and 1,100 crore from existing capacity. Sub segment level unrealised potentials were also disclosed in several sections.
The presentation stated incremental profit was led by Atul Bioscience Ltd and Atul Products Ltd. It also provided sales and PBT for DPD Ltd, Amal Ltd (associate), Anaven LLP (JV) and Rudolf Atul Chemicals Ltd (JV).
Five mandates were listed: excellence in R and D, technology and manufacturing; pervasive technology including AI; world class people productivity and lean fixed cost; conserve cash with performance measured by free cash flow; and work closely with customers to identify big ideas but start small.
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker